Proteomic analysis of the herpes simplex virus 1 virion protein 16 transactivator protein in infected cells

Proteomics

Volumn 15, Issue 12, 2015, Pages 1957-1967

  Suk, Hyung ^a   Knipe, David M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Herpes simplex virus; ICP4; Infected; Microbiology; VP16

Indexed keywords

CELL PROTEIN; HOST CELL FACTOR 1; INFECTED CELL PROTEIN 4; OCTAMER TRANSCRIPTION FACTOR 1; PROTEIN VP16; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; HERPES SIMPLEX VIRUS IE3 PROTEIN, HUMAN HERPESVIRUS 1; IMMEDIATE EARLY PROTEIN; PROTEOME; TRANSACTIVATOR PROTEIN;

ARTICLE; GENE EXPRESSION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEOMICS; SKIN FIBROBLAST; TRANSACTIVATION; ANIMAL; BONE TUMOR; CELL CULTURE; CHLOROCEBUS AETHIOPS; CYTOLOGY; FIBROBLAST; HERPES SIMPLEX; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; METABOLISM; OSTEOSARCOMA; PATHOLOGY; PHYSIOLOGY; PROCEDURES; VERO CELL LINE; VIROLOGY;

HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

ANIMALS; BONE NEOPLASMS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; FIBROBLASTS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS PROTEIN VMW65; HERPESVIRUS 1, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; OSTEOSARCOMA; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANS-ACTIVATORS; VERO CELLS;

EID: 84930971966     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201500020     Document Type: Article

References (97)

1. DeCaprio, J. A., Ludlow, J. W., Figge, J., Shew, J. Y. et al., SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988, 54, 275-283.
2. Lane, D. P., Crawford, L. V., T antigen is bound to a host protein in SV40-transformed cells. Nature 1979, 278, 261-263.
3. Kress, M., May, E., Cassingena, R., May, P., Simian virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum. J. Virol. 1979, 31, 472-483.
4. Linzer, D. I., Levine, A. J., Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 1979, 17, 43-52.
5. Sarnow, P., Ho, Y. S., Williams, J., Levine, A. J., Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 1982, 28, 387-394.
6. Harlow, E., Whyte, P., Franza, B. R., Jr., Schley, C., Association of adenovirus early-region 1A proteins with cellular polypeptides. Mol. Cell. Biol. 1986, 6, 1579-1589.
7. Whyte, P., Williamson, N. M., Harlow, E., Cellular targets for transformation by the adenovirus E1A proteins. Cell 1989, 56, 67-75.
8. Werness, B. A., Levine, A. J., Howley, P. M., Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990, 248, 76-79.
9. Dyson, N., Howley, P. M., Munger, K., Harlow, E., The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989, 243, 934-937.
10. Scheffner, M., Huibregtse, J. M., Vierstra, R. D., Howley, P. M., The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993, 75, 495-505.
11. Taylor, T. J., Knipe, D. M., Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8. J. Virol. 2004, 78, 5856-5866.
12. Rice, S. A., Su, L. S., Knipe, D. M., Herpes simplex virus alpha protein ICP27 possesses separable positive and negative regulatory activities. J. Virol. 1989, 63, 3399-3407.
13. Su, L., Knipe, D. M., Herpes simplex virus alpha protein ICP27 can inhibit or augment viral gene transactivation. Virology 1989, 170, 496-504.
14. Sekulovich, R. E., Leary, K., Sandri-Goldin, R. M., The herpes simplex virus type 1 alpha protein ICP27 can act as a trans-repressor or a trans-activator in combination with ICP4 and ICP0. J. Virol.1988, 62, 4510-4522.
15. Rice, S. A., Knipe, D. M., Gene-specific transactivation by herpes simplex virus type 1 alpha protein ICP27. J. Virol. 1988, 62, 3814-3823.
16. Jean, S., LeVan, K. M., Song, B., Levine, M., Knipe, D. M., Herpes simplex virus 1 ICP27 is required for transcription of two viral late (gamma 2) genes in infected cells. Virology 2001, 283, 273-284.
17. Sacks, W. R., Greene, C. C., Aschman, D. P., Schaffer, P. A., Herpes simplex virus type 1 ICP27 is an essential regulatory protein. J. Virol. 1985, 55, 796-805.
18. Fontaine-Rodriguez, E. C., Taylor, T. J., Olesky, M., Knipe, D. M., Proteomics of herpes simplex virus infected cell protein 27: association with translation initiation factors. Virology 2004, 330, 487-492.
19. Koleske, A. J., Buratowski, S., Nonet, M., Young, R. A., A novel transcription factor reveals a functional link between the RNA polymerase II CTD and TFIID. Cell 1992, 69, 883-894.
20. Biddick, R., Young, E. T., Yeast mediator and its role in transcriptional regulation. C. R. Biol. 2005, 328, 773-782.
21. Malik, S., Baek, H. J., Wu, W., Roeder, R. G., Structural and functional characterization of PC2 and RNA polymerase II-associated subpopulations of metazoan mediator. Mol. Cell. Biol. 2005, 25, 2117-2129.
22. Ranish, J. A., Yudkovsky, N., Hahn, S., Intermediates in formation and activity of the RNA polymerase II preinitiation complex: holoenzyme recruitment and a postrecruitment role for the TATA box and TFIIB. Genes Dev. 1999, 13, 49-63.
23. Cantin, G. T., Stevens, J. L., Berk, A. J., Activation domain-mediator interactions promote transcription preinitiation complex assembly on promoter DNA. Proc. Natl. Acad. Sci. U S A 2003, 100, 12003-12008.
24. Ding, N., Zhou, H., Esteve, P. O., Chin, H. G. et al., Mediator links epigenetic silencing of neuronal gene expression with x-linked mental retardation. Mol. Cell 2008, 31, 347-359.
25. Ding, N., Tomomori-Sato, C., Sato, S., Conaway, R. C. et al., MED19 and MED26 are synergistic functional targets of the RE1 silencing transcription factor in epigenetic silencing of neuronal gene expression. J. Biol. Chem. 2009, 284, 2648-2656.
26. Hahn, M., Dambacher, S., Dulev, S., Kuznetsova, A. Y. et al., Suv4-20h2 mediates chromatin compaction and is important for cohesin recruitment to heterochromatin. Genes Dev. 2013, 27, 859-872.
27. Tsutsui, T., Fukasawa, R., Shinmyouzu, K., Nakagawa, R. et al., Mediator complex recruits epigenetic regulators via its two cyclin-dependent kinase subunits to repress transcription of immune response genes. J. Biol. Chem. 2013, 288, 20955-20965.
28. Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J. et al., Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 2013, 153, 307-319.
29. Loven, J., Hoke, H. A., Lin, C. Y., Lau, A. et al., Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 2013, 153, 320-334.
30. Malik, S., Barrero, M. J., Jones, T., Identification of a regulator of transcription elongation as an accessory factor for the human Mediator coactivator. Proc. Natl. Acad. Sci. USA 2007, 104, 6182-6187.
31. Donner, A. J., Ebmeier, C. C., Taatjes, D. J., Espinosa, J. M., CDK8 is a positive regulator of transcriptional elongation within the serum response network. Nat. Struct. Mol. Biol. 2010, 17, 194-201.
32. Takahashi, H., Parmely, T. J., Sato, S., Tomomori-Sato, C. et al., Human mediator subunit MED26 functions as a docking site for transcription elongation factors. Cell 2011, 146, 92-104.
33. Mukundan, B., Ansari, A., Novel role for mediator complex subunit Srb5/Med18 in termination of transcription. J. Biol. Chem. 2011, 286, 37053-37057.
34. Huang, Y., Li, W., Yao, X., Lin, Q. J. et al., Mediator complex regulates alternative mRNA processing via the MED23 subunit. Mol. Cell 2012, 45, 459-469.
35. Rachez, C., Lemon, B. D., Suldan, Z., Bromleigh, V. et al., Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 1999, 398, 824-828.
36. Kang, Y. K., Guermah, M., Yuan, C. X., Roeder, R. G., The TRAP/mediator coactivator complex interacts directly with estrogen receptors alpha and beta through the TRAP220 subunit and directly enhances estrogen receptor function in vitro. Proc. Natl. Acad. Sci. USA 2002, 99, 2642-2647.
37. Yang, F., Vought, B. W., Satterlee, J. S., Walker, A. K. et al., An ARC/mediator subunit required for SREBP control of cholesterol and lipid homeostasis. Nature 2006, 442, 700-704.
38. Yin, J. W., Wang, G., The mediator complex: a master coordinator of transcription and cell lineage development. Development 2014, 141, 977-987.
39. Roizman, B., Knipe, D. M., Whitley, R. J., in: Knipe, D. M., Howley, P. M. (Eds.), Fields Virology, Lippincott Williams & Wilkins, Philadelphia 2013, pp. 1823-1897.
40. Knipe, D. M., Lieberman, P. M., Jung, J. U., McBride, A. A. et al., Snapshots: chromatin control of viral infection. Virology 2013, 435, 141-156.
41. Greaves, R. F., O'Hare, P., Structural requirements in the herpes simplex virus type 1 transactivator Vmw65 for interaction with the cellular octamer-binding protein and target TAATGARAT sequences. J. Virol. 1990, 64, 2716-2724.
42. Liu, Y., Gong, W., Huang, C. C., Herr, W., Cheng, X., Crystal structure of the conserved core of the herpes simplex virus transcriptional regulatory protein VP16. Genes Dev. 1999, 13, 1692-1703.
43. Uesugi, M., Nyanguile, O., Lu, H., Levine, A. J., Verdine, G. L., Induced alpha helix in the VP16 activation domain upon binding to a human TAF. Science 1997, 277, 1310-1313.
44. Kobayashi, N., Boyer, T. G., Berk, A. J., A class of activation domains interacts directly with TFIIA and stimulates TFIIA-TFIID-promoter complex assembly. Mol. Cell. Biol. 1995, 15, 6465-6473.
45. Lin, Y. S., Ha, I., Maldonado, E., Reinberg, D., Green, M. R., Binding of general transcription factor TFIIB to an acidic activating region. Nature 1991, 353, 569-571.
46. Stringer, K. F., Ingles, C. J., Greenblatt, J., Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID. Nature 1990, 345, 783-786.
47. Ingles, C. J., Shales, M., Cress, W. D., Triezenberg, S. J., Greenblatt, J., Reduced binding of TFIID to transcriptionally compromised mutants of VP16. Nature 1991, 351, 588-590.
48. Xiao, H., Pearson, A., Coulombe, B., Truant, R. et al., Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol. Cell. Biol. 1994, 14, 7013-7024.
49. Ito, M., Yuan, C. X., Malik, S., Gu, W. et al., Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol. Cell. 1999, 3, 361-370.
50. Park, J. M., Kim, H. S., Han, S. J., Hwang, M. S. et al., In vivo requirement of activator-specific binding targets of mediator. Mol. Cell. Biol. 2000, 20, 8709-8719.
51. Mittler, G., Stuhler, T., Santolin, L., Uhlmann, T. et al., A novel docking site on Mediator is critical for activation by VP16 in mammalian cells. EMBO J. 2003, 22, 6494-6504.
52. Huang, J., Kent, J. R., Placek, B., Whelan, K. A. et al., Trimethylation of histone H3 lysine 4 by Set1 in the lytic infection of human herpes simplex virus 1. J. Virol. 2006, 80, 5740-5746.
53. Liang, Y., Vogel, J. L., Narayanan, A., Peng, H., Kristie, T. M., Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency. Nat. Med. 2009, 15, 1312-1317.
54. Liang, Y., Vogel, J. L., Arbuckle, J. H., Rai, G. et al., Targeting the JMJD2 histone demethylases to epigenetically control herpesvirus infection and reactivation from latency. Sci. Transl. Med. 2013, 5, 167ra165.
55. Placek, B. J., Huang, J., Kent, J. R., Dorsey, J. et al., The histone variant H3.3 regulates gene expression during lytic infection with herpes simplex virus type 1. J. Virol. 2009, 83, 1416-1421.
56. Peng, H., Nogueira, M. L., Vogel, J. L., Kristie, T. M., Transcriptional coactivator HCF-1 couples the histone chaperone Asf1b to HSV-1 DNA replication components. Proc. Natl. Acad. Sci. USA 2010, 107, 2461-2466.
57. Ferenczy, M. W., DeLuca, N. A., Epigenetic modulation of gene expression from quiescent herpes simplex virus genomes. J. Virol. 2009, 83, 8514-8524.
58. Cliffe, A. R., Knipe, D. M., Herpes simplex virus ICP0 promotes both histone removal and acetylation on viral DNA during lytic infection. J. Virol. 2008, 82, 12030-12038.
59. Grondin, B., DeLuca, N., Herpes simplex virus type 1 ICP4 promotes transcription preinitiation complex formation by enhancing the binding of TFIID to DNA. J. Virol. 2000, 74, 11504-11510.
60. Gu, B., DeLuca, N., Requirements for activation of the herpes simplex virus glycoprotein C promoter in vitro by the viral regulatory protein ICP4. J. Virol. 1994, 68, 7953-7965.
61. Godowski, P. J., Knipe, D. M., Transcriptional control of herpesvirus gene expression: gene functions required for positive and negative regulation. Proc. Natl. Acad. Sci. USA 1986, 83, 256-260.
62. Beard, P., Faber, S., Wilcox, K. W., Pizer, L. I., Herpes simplex virus immediate early infected-cell polypeptide 4 binds to DNA and promotes transcription. Proc. Natl. Acad. Sci. USA 1986, 83, 4016-4020.
63. Preston, C. M., Abnormal properties of an immediate early polypeptide in cells infected with the herpes simplex virus type 1 mutant tsK. J. Virol. 1979, 32, 357-369.
64. Carrozza, M. J., DeLuca, N. A., Interaction of the viral activator protein ICP4 with TFIID through TAF250. Mol. Cell. Biol. 1996, 16, 3085-3093.
65. Lester, J. T., DeLuca, N. A., Herpes simplex virus 1 ICP4 forms complexes with TFIID and mediator in virus-infected cells. J. Virol. 2011, 85, 5733-5744.
66. Park, J. M., Kim, J. M., Kim, L. K., Kim, S. N. et al., Signal-induced transcriptional activation by Dif requires the dTRAP80 mediator module. Mol. Cell. Biol. 2003, 23, 1358-1367.
67. Yang, F., DeBeaumont, R., Zhou, S., Naar, A. M., The activator-recruited cofactor/mediator coactivator subunit ARC92 is a functionally important target of the VP16 transcriptional activator. Proc. Natl. Acad. Sci. USA 2004, 101, 2339-2344.
68. Trinkle-Mulcahy, L., Resolving protein interactions and complexes by affinity purification followed by label-based quantitative mass spectrometry. Proteomics 2012, 12, 1623-1638.
69. Miteva, Y. V., Budayeva, H. G., Cristea, I. M., Proteomics-based methods for discovery, quantification, and validation of protein-protein interactions. Anal. Chem. 2013, 85, 749-768.
70. Moorman, N. J., Sharon-Friling, R., Shenk, T., Cristea, I. M., A targeted spatial-temporal proteomics approach implicates multiple cellular trafficking pathways in human cytomegalovirus virion maturation. Mol. Cell. Proteomics 2010, 9, 851-860.
71. Lin, A. E., Greco, T. M., Dohner, K., Sodeik, B., Cristea, I. M., A proteomic perspective of inbuilt viral protein regulation: pUL46 tegument protein is targeted for degradation by ICP0 during herpes simplex virus type 1 infection. Mol. Cell. Proteomics 2013, 12, 3237-3252.
72. Carpp, L. N., Rogers, R. S., Moritz, R. L., Aitchison, J. D., Quantitative proteomic analysis of host-virus interactions reveals a role for Golgi brefeldin A resistance factor 1 (GBF1) in dengue infection. Mol. Cell. Proteomics 2014, 13, 2836-2854.
73. Ottosen, S., Herrera, F. J., Doroghazi, J. R., Hull, A. et al., Phosphorylation of the VP16 transcriptional activator protein during herpes simplex virus infection and mutational analysis of putative phosphorylation sites. Virology 2006, 345, 468-481.
74. LaBoissiere, S., Izeta, A., Malcomber, S., O'Hare, P., Compartmentalization of VP16 in cells infected with recombinant herpes simplex virus expressing VP16-green fluorescent protein fusion proteins. J. Virol. 2004, 78, 8002-8014.
75. Schaffer, P., Vonka, V., Lewis, R., Benyesh-Melnick, M., Temperature-sensitive mutants of herpes simplex virus. Virology 1970, 42, 1144-1146.
76. Showalter, S. D., Zweig, M., Hampar, B., Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4. Infect. Immun. 1981, 34, 684-692.
77. Knipe, D. M., Smith, J. L., A mutant herpesvirus protein leads to a block in nuclear localization of other viral proteins. Mol. Cell. Biol. 1986, 6, 2371-2381.
78. Shevchenko, A., Wilm, M., Vorm, O., Mann, M., Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68, 850-858.
79. Eng, J. K., McCormack, A. L., Yates, J. R., An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am. Soc. Mass Spectrom. 1994, 5, 976-989.
80. Shannon, P., Markiel, A., Ozier, O., Baliga, N. S. et al., Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003, 13, 2498-2504.
81. Bindea, G., Mlecnik, B., Hackl, H., Charoentong, P. et al., ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 2009, 25, 1091-1093.
82. Oh, H. S., Bryant, K. F., Nieland, T. J., Mazumder, A. et al., A targeted RNA interference screen reveals novel epigenetic factors that regulate herpesviral gene expression. MBio 2014, 5, e01086-e01013.
83. Silva, L., Oh, H. S., Chang, L., Yan, Z. et al., Roles of the nuclear lamina in stable nuclear association and assembly of a herpesviral transactivator complex on viral immediate-early genes. MBio 2012, 3, e00300-e00311.
84. Kristie, T. M., Sharp, P. A., Interactions of the Oct-1 POU subdomains with specific DNA sequences and with the HSV alpha-trans-activator protein. Genes Dev. 1990, 4, 2383-2396.
85. Tomomori-Sato, C., Sato, S., Parmely, T. J., Banks, C. A. et al., A mammalian mediator subunit that shares properties with Saccharomyces cerevisiae mediator subunit Cse2. J. Biol. Chem. 2004, 279, 5846-5851.
86. Naar, A. M., Beaurang, P. A., Zhou, S., Abraham, S. et al., Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature 1999, 398, 828-832.
87. Boyer, T. G., Martin, M. E., Lees, E., Ricciardi, R. P., Berk, A. J., Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein. Nature 1999, 399, 276-279.
88. Uhlmann, T., Boeing, S., Lehmbacher, M., Meisterernst, M., The VP16 activation domain establishes an active mediator lacking CDK8 in vivo. J. Biol. Chem. 2007, 282, 2163-2173.
89. Sato, S., Tomomori-Sato, C., Banks, C. A., Parmely, T. J. et al., A mammalian homolog of Drosophila melanogaster transcriptional coactivator intersex is a subunit of the mammalian mediator complex. J. Biol. Chem. 2003, 278, 49671-49674.
90. Daou, S., Mashtalir, N., Hammond-Martel, I., Pak, H. et al., Crosstalk between O-GlcNAcylation and proteolytic cleavage regulates the host cell factor-1 maturation pathway. Proc. Natl. Acad. Sci. USA 2011, 108, 2747-2752.
91. Vittone, V., Diefenbach, E., Triffett, D., Douglas, M. W. et al., Determination of interactions between tegument proteins of herpes simplex virus type 1. J. Virol. 2005, 79, 9566-9571.
92. Smibert, C. A., Popova, B., Xiao, P., Capone, J. P., Smiley, J. R., Herpes simplex virus VP16 forms a complex with the virion host shutoff protein vhs. J. Virol. 1994, 68, 2339-2346.
93. Elliott, G., Mouzakitis, G., O'Hare, P., VP16 interacts via its activation domain with VP22, a tegument protein of herpes simplex virus, and is relocated to a novel macromolecular assembly in coexpressing cells. J. Virol. 1995, 69, 7932-7941.
94. Gross, S. T., Harley, C. A., Wilson, D. W., The cytoplasmic tail of Herpes simplex virus glycoprotein H binds to the tegument protein VP16 in vitro and in vivo. Virology 2003, 317, 1-12.
95. Maringer, K., Stylianou, J., Elliott, G., A network of protein interactions around the herpes simplex virus tegument protein VP22. J. Virol. 2012, 86, 12971-12982.
96. Wagner, L. M., DeLuca, N. A., Temporal association of herpes simplex virus ICP4 with cellular complexes functioning at multiple steps in PolII transcription. PLoS One 2013, 8, e78242.
97. Quinlan, M. P., Knipe, D. M., Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions. Mol. Cell. Biol. 1985, 5, 957-963.